Spruce Biosciences Common Stock Technical Analysis
| SPRB Stock | USD 81.52 3.72 4.36% |
As of the 25th of January, Spruce Biosciences has the Coefficient Of Variation of (939.59), variance of 42.26, and Risk Adjusted Performance of (0.07). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Spruce Biosciences Common, as well as the relationship between them.
Spruce Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Spruce, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SpruceSpruce Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Spruce Biosciences Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 230.5 | Hold | 5 | Odds |
Most Spruce analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Spruce stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Spruce Biosciences Common, talking to its executives and customers, or listening to Spruce conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spruce Biosciences. If investors know Spruce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spruce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (84.32) | Revenue Per Share | Quarterly Revenue Growth (0.76) | Return On Assets | Return On Equity |
The market value of Spruce Biosciences Common is measured differently than its book value, which is the value of Spruce that is recorded on the company's balance sheet. Investors also form their own opinion of Spruce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Spruce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spruce Biosciences' market value can be influenced by many factors that don't directly affect Spruce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spruce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spruce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spruce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Spruce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spruce Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spruce Biosciences.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in Spruce Biosciences on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Spruce Biosciences Common or generate 0.0% return on investment in Spruce Biosciences over 90 days. Spruce Biosciences is related to or competes with NRX Pharmaceuticals, Werewolf Therapeutics, OUTLOOK THERAPEUTICS, IO Biotech, Cue Biopharma, OS Therapies, and VTv Therapeutics. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rar... More
Spruce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spruce Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spruce Biosciences Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 31.24 | |||
| Value At Risk | (9.96) | |||
| Potential Upside | 10.15 |
Spruce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spruce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spruce Biosciences' standard deviation. In reality, there are many statistical measures that can use Spruce Biosciences historical prices to predict the future Spruce Biosciences' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.31) | |||
| Treynor Ratio | 2.48 |
Spruce Biosciences January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 2.49 | |||
| Mean Deviation | 5.18 | |||
| Coefficient Of Variation | (939.59) | |||
| Standard Deviation | 6.5 | |||
| Variance | 42.26 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.31) | |||
| Treynor Ratio | 2.48 | |||
| Maximum Drawdown | 31.24 | |||
| Value At Risk | (9.96) | |||
| Potential Upside | 10.15 | |||
| Skewness | 0.1641 | |||
| Kurtosis | 0.1468 |
Spruce Biosciences Common Backtested Returns
Spruce Biosciences Common owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0742, which indicates the firm had a -0.0742 % return per unit of risk over the last 3 months. Spruce Biosciences Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spruce Biosciences' Coefficient Of Variation of (939.59), risk adjusted performance of (0.07), and Variance of 42.26 to confirm the risk estimate we provide. The entity has a beta of -0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Spruce Biosciences are expected to decrease at a much lower rate. During the bear market, Spruce Biosciences is likely to outperform the market. At this point, Spruce Biosciences Common has a negative expected return of -0.47%. Please make sure to validate Spruce Biosciences' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Spruce Biosciences Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.41 |
Average predictability
Spruce Biosciences Common has average predictability. Overlapping area represents the amount of predictability between Spruce Biosciences time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spruce Biosciences Common price movement. The serial correlation of 0.41 indicates that just about 41.0% of current Spruce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.41 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 19.43 |
Spruce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Spruce Biosciences Common Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Spruce Biosciences Common volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Spruce Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Spruce Biosciences Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Spruce Biosciences Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Spruce Biosciences Common price pattern first instead of the macroeconomic environment surrounding Spruce Biosciences Common. By analyzing Spruce Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Spruce Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Spruce Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 5.73 | 6.59 | 10.47 | Revenue Per Share | 9.15 | 10.53 | 16.12 |
Spruce Biosciences January 25, 2026 Technical Indicators
Most technical analysis of Spruce help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Spruce from various momentum indicators to cycle indicators. When you analyze Spruce charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 2.49 | |||
| Mean Deviation | 5.18 | |||
| Coefficient Of Variation | (939.59) | |||
| Standard Deviation | 6.5 | |||
| Variance | 42.26 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.31) | |||
| Treynor Ratio | 2.48 | |||
| Maximum Drawdown | 31.24 | |||
| Value At Risk | (9.96) | |||
| Potential Upside | 10.15 | |||
| Skewness | 0.1641 | |||
| Kurtosis | 0.1468 |
Spruce Biosciences January 25, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Spruce stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.08 | ||
| Daily Balance Of Power | (0.54) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 83.02 | ||
| Day Typical Price | 82.52 | ||
| Price Action Indicator | (3.36) | ||
| Market Facilitation Index | 6.93 |
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |